Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SINEMET CR
- Dopaminergic Therapy for Anhedonia - 2
- Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
- Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke
- Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product
- Novel Non-opioid Post-surgical Pain Treatment in Females
- DTA (Dopaminergic Therapy for Anhedonia) Study
- Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing
- Improving Quality of Life in Early Parkinson's Disease
- 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)
- Effects of 5HTP and LDOPA on CNS Excitability After SCI
- Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis
- Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)
- WD-1603 PK Study in Healthy Volunteers
- PF 06412562 in Subjects With Advanced Stage Parkinson's Disease
- Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients
- A Randomized Controlled Trial of Nicotinamide Supplementation in Early Parkinson's Disease
- A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
- Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
- Measuring Parkinson's Disease Progression
- Pharmacokinetic of Levodopa Study in Healthy Males
- Norepinephrine-targeted Therapy for Action Control in Parkinson Disease
- Dose-finding Pharmacokinetic Study in Healthy Males
- Dose Ranging Study of Carbidopa-levodopa
- Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients
- A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets
- Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa
- Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)
- The Effect of Dopamine on Diabetic Retinopathy
- A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients
- Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia
- Pharmacokinetic Study in Healthy Volunteers
- Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa
- A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)
- Effect of Serotonin and Levodopa in Ischemic Stroke
- Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation
- Pharmacokinetic Study in Healthy Males
- A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
- Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa
- Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa
- Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects
- Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
- Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
- Erythromycin in Parkinson's Disease
- Effect of L-dopa In Subacute Back Pain Population
- Vision Response to Dopamine Replacement
- Antipsychotic Augmentation With L-Dopa
- Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients
- A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067
- Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
- Augmenting Language Therapy for Aphasia: Levodopa
- Use of Zolpidem in Parkinson's Disease
- A Trial of Levodopa in Angelman Syndrome
- A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
- Levodopa Concentration Profile With Stalevo 75/125 mg
- An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects
- Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
- High and Low Dose Carbidopa Treatment of Parkinson's Disease
- Neurobiological Principles Applied to the Rehabilitation of Stroke Patients
- Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence
- Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study
- PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
- Augmenting Effects of L-DOPS With Carbidopa and Entacapone
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
- A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
- Substance Abuse Pre-Treatment Screening Study
- Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's
- SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole
- Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease
- Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
- Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.
- A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease
- Talampanel to Treat Parkinson's Disease
- Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
- Lisuride Patch to Treat Parkinson's Disease
- ACP-103 to Treat Parkinson's Disease
- Levetiracetam Treatment of L-dopa Induced Dyskinesias
- JP-1730 to Treat Parkinson's Disease
- Effects of Talampanel on Patients With Advanced Parkinson's Disease
- Riluzole to Treat Parkinson's Disease
- EMD 128130 for the Treatment of Parkinson's Disease
- KW-6002 to Treat Parkinson's Disease
- Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease
- Timing of Levodopa Treatment in Parkinson's Disease
- Study of LY300164 for the Treatment of Parkinson's Disease
Clinical trials list
click for details